JESSICA ARTH: Open Payments
NPI 1578995890 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 65 payments from 22 companies in 2025. Trend: 2023 $2,194 · 2024 $1,657 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $155 |
| Amgen Inc. | 12 | $147 |
| ABBVIE INC. | 11 | $147 |
| Corcept Therapeutics | 5 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| SANOFI-AVENTIS U.S. LLC | 2 | $53 |
| Lundbeck LLC | 2 | $52 |
| PFIZER INC. | 3 | $49 |
| Lilly USA, LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
Products named: Korlym, OTEZLA, UBRELVY, CAPLYTA, Ozempic, TZIELD, VYEPTI, MOUNJARO.
Industry payments across TN — which companies pay providers there.
